References
- Pfaller MA. Infection control: opportunistic fungal infec-tions-the increasing importance of Candida species. Infect Control Hosp Epidemiol 1989; 10: 270–273.
- Edwards JE, Turkel SB, Elder HA, Rand RW, Guze LB. Hematogenous Candida osteomyelitis: report of three cases and review of literature. Am J Med 1975; 59: 89–94.
- Dijkmans BAC, Koolen MI, Mouton RP, Falke THM, van den Broek PJ, van der Meer JWM. Hemtogenous Candida vertebral osteomyelitis treated with ketoconazole. Infection 1982; 10: 290–292.
- Eisen DP, MacGinley R, Christensson B, Larsson L, Woods ML. Candida tropicalis vertebral osteomyelitis compli-cating epidural catheterisation with disease paralleled by ele-vated D-arabinitol/L-arabintol ratios. Eur J Clin Microbiol Infect Dis 2000; 19: 61–63.
- Gathe JC, Harris RL, Garland B, Bradshaw MW, Williams TW. Candida osteomyelitis: report of five cases and review of the literature. Am Med J 1987; 82: 927–937.
- Shaikh BS, Appelbaum PC, Aber RC. Vertebral disc space infection and osteomyelitis due to Candida albicans in a patient with acute myelomonocytic leukemia. Cancer 1980; 45: 1025–1028.
- Lasday SD, Jay RM. Candida osteomyelitis. J Foot-Ankle Surg 1994; 33: 173–176.
- Almekinders LC, Greene WB. Vertebral Candida infec-tions: a case report and review of the literature. Clin Orthoped Related Res 1991; 267: 174–178.
- Freidman BC, Simon GL. Candida vertebral osteomyelitis: report of three cases and a review of the litera-ture. Diagn Microbiol Infect Dis 1987; 8: 31–36.
- McCullers JA, Flynn PM. Candida tropicalis osteomyelitis: case report and review. Clin Infect Dis 1998; 26: 1000–1001.
- Warren NG, Hazen KC. Candida, Cryptococcus and other Yeast of Medical Importance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press. 1999: 1184–1199.
- Bostock A, Khattak MN, Matthews R, Burnie J. Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans. J Gen Microbiol 1993; 139: 2179–2184.
- Robert F, Lebreton F, Bougnoux ME, et al. Use of ran-dom amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 1995; 33: 2366–2371.
- Steffan P, Vazquez JA, Boikov D, Xu C, Sobel JD, Akins RA. Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 1997; 35: 2031–2039.
- Edwards JE, Jr. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Disease. 5th ed. Phil-adelphia, PS: Churchill Livingstone, 2000: 2657.
- Forsgren A, Schmeling D, Quie PG. Effect of tetracy-cline on the phagocytic function of human leucocytes. J Infect Dis 1974; 130: 412–415.
- Sugar AM, Saunders C, Diamond RD. Successful treat-ment of Candida osteomyelitis with fluconazole, a noncom-parative study of two patients. Diagn Microbiol Infect Dis 1990; 13: 517–520.
- Tang C. Successful treatment of Candida albicans osteomyelitis with fluconazole. J Infect 1993; 26: 89–92.
- Bennett JE. Antifungal agents. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill Co. Inc. 2001: 1305
- Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662–678.